Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Dexcom (DXCM)
NASDAQ:DXCM
Dexcom (DXCM) Stock Price & Analysis
3,141 Followers
DXCM Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$74.75 - $142.00
Previous Close$124.95
Volume1.01M
Average Volume (3M)3.00M
Market Cap
$49.80B
Enterprise Value$51.66B
Total Cash (Recent Filing)$566.30M
Total Debt (Recent Filing)$2.54B
Price to Earnings (P/E)80.7
Beta0.99
Next Earnings
Jul 25, 2024EPS Estimate
$0.39Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.55
Shares Outstanding397,683,837
10 Day Avg. Volume2,167,737
30 Day Avg. Volume2,998,153
Standard Deviation0.15
R-Squared0.20
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)26.47
Price to Sales (P/S)48.84
Price to Cash Flow (P/CF)94.60
P/FCF Ratio146.90
Enterprise Value/Market CapN/A
Enterprise Value/Revenue14.26
Enterprise Value/Gross Profit22.57
Enterprise Value/Ebitda56.07
Forecast
1Y Price Target
$155.31Price Target Upside24.02% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering16
Dexcom News
PremiumStock Analysis & Ideas
ABT, DHR, DXCM: Which “Strong Buy” Healthcare Stock Has More Upside?
Bulls Say, Bears Say
Bulls Say
Financial PerformanceDXCM delivered better-than-expected 1Q results and raised the lower end of its 2024 revenue guidance range.
Market Share GrowthDXCM’s core CGM business is continuing to gain market share in both the US and OUS.
Product LaunchStelo's upcoming US launch and over-the-counter approval present new market opportunities and potential for revenue expansion.
Bears Say
Financial PerformanceGross Margin (GM%) contracted from the previous year and was below analyst expectations.
Future RevenueThe adjusted revenue guidance indicates a slight decrease from prior market consensus expectations.
Product PerformanceApproximately 20% of sensors may not last for the full 15 days, 10% of these sensors may last less than 12 days.
---
Ownership Overview
2.82% Insiders
35.13% Mutual Funds
40.94% Other Institutional Investors
21.11% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
DXCM FAQ
What was Dexcom’s price range in the past 12 months?
Dexcom lowest stock price was $74.75 and its highest was $142.00 in the past 12 months.
What is Dexcom’s market cap?
Currently, no data Available
When is Dexcom’s upcoming earnings report date?
Dexcom’s upcoming earnings report date is Jul 25, 2024 which is in 72 days.
How were Dexcom’s earnings last quarter?
Dexcom released its earnings results on Apr 25, 2024. The company reported $0.32 earnings per share for the quarter, beating the consensus estimate of $0.271 by $0.049.
Is Dexcom overvalued?
According to Wall Street analysts Dexcom’s price is currently Undervalued.
Does Dexcom pay dividends?
Dexcom does not currently pay dividends.
What is Dexcom’s EPS estimate?
Dexcom’s EPS estimate is $0.39.
How many shares outstanding does Dexcom have?
Dexcom has 397,683,840 shares outstanding.
What happened to Dexcom’s price movement after its last earnings report?
Dexcom reported an EPS of $0.32 in its last earnings report, beating expectations of $0.271. Following the earnings report the stock price went down -9.905%.
Which hedge fund is a major shareholder of Dexcom?
Among the largest hedge funds holding Dexcom’s share is Sands Capital Management LLC. It holds Dexcom’s shares valued at 2B.
---
Dexcom Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$155.31 (24.02% Upside)
$155.31 (24.02% Upside)
Blogger Sentiment
Bullish
DXCM Sentiment 83%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 2.2M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.4%
Last 30 Days ▼ 2.2%
Last 30 Days ▼ 2.2%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
2.67%
12-Months-Change
Fundamentals
Return on Equity
28.54%
Trailing 12-Months
Asset Growth
17.52%
Trailing 12-Months
Company Description
Dexcom
California-based DexCom, Inc. is a medical device manufacturing company. The company designs, develops and focuses on commercialization of continuous glucose monitoring (CGM) systems for ambulatory use by people with diabetes. Its products include DexCom G4 PLATINUM System, DexCom G5 Mobil, DexCom G6, and DexCom Share.
---
DXCM Company Deck
---
DXCM Earnings Call
Q1 2024
0:00 / 0:00
---
DXCM Revenue Breakdown
72.48% U.S.
27.52% Outside of the U.S.
---
DXCM Stock 12 Month Forecast
Average Price Target
$155.31
▲(24.02% Upside)
Technical Analysis
Best Analysts Covering DXCM
1 Year
1 Year Success Rate
17/20 ratings generated profit
1 Year Average Return
+37.34%
reiterated a buy rating 19 days ago
Copying Mathew Blackman's trades and holding each position for 1 Year would result in 85.00% of your transactions generating a profit, with an average return of +37.34% per trade.
---